AR and neoplasm: To identify the downstream pathway involved in AR mutation-associated hepatocarcinogenesis, we performed chromatin immunoprecipitation sequencing (ChIP-seq) and RNA sequencing (RNA-seq) on tumor tissues and benign liver tissues from ARQ62L, ARE81Q and ARWT groups.